Jinghua Pharmaceutical Group Co., Ltd.
Shenzhen Stock ExchangeTotal Valuation
Jinghua Pharmaceutical Group Co., Ltd. carries a market capitalization of 5.53B, placing it among publicly traded companies globally. Its enterprise value stands at 5.15B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 5.53B |
| Enterprise Value | 5.15B |
Share Statistics
Jinghua Pharmaceutical Group Co., Ltd. currently has 829.67M shares outstanding.
| Shares Outstanding | 829.67M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
Jinghua Pharmaceutical Group Co., Ltd. trades at a trailing price-to-earnings ratio of 28.17. The price-to-sales ratio is 4.14, and the price-to-book ratio stands at 3.33.
| PE Ratio | 28.17 |
| PS Ratio | 4.14 |
| PB Ratio | 3.33 |
| P/TBV Ratio | 2.09 |
| P/FCF Ratio | 342.96 |
| P/OCF Ratio | N/A |
Enterprise Valuation
On an enterprise value basis, Jinghua Pharmaceutical Group Co., Ltd. trades at an EV/EBITDA multiple of 19.20 and an EV/FCF ratio of 296.39. The EV/Sales ratio of 3.64 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 19.20 provides insight into valuation relative to core operating earnings.
| EV / Sales | 3.64 |
| EV / EBITDA | 19.20 |
| EV / EBIT | 19.20 |
| EV / FCF | 296.39 |
Financial Position
Jinghua Pharmaceutical Group Co., Ltd. maintains a current ratio of 4.99, meaning it holds 5.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 0.01, indicating conservative leverage, while an interest coverage ratio of 790.43 demonstrates strong ability to service its debt obligations.
| Current Ratio | 4.99 |
| Quick Ratio | 2.89 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.00 |
| Interest Coverage | 790.43 |
Financial Efficiency
Jinghua Pharmaceutical Group Co., Ltd. posts a return on equity of 12.31 and a return on invested capital of 7.88.
| Return on Equity (ROE) | 12.31 |
| Return on Assets (ROA) | 6.29 |
| Return on Invested Capital (ROIC) | 7.88 |
| Return on Capital Employed (ROCE) | 8.30 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 2.40 |
Taxes
Over the trailing twelve months, Jinghua Pharmaceutical Group Co., Ltd. has paid 41.68M in income taxes, reflecting an effective tax rate of 14.58.
| Income Tax | 41.68M |
| Effective Tax Rate | 14.58 |
Stock Price Statistics
Jinghua Pharmaceutical Group Co., Ltd.'s stock has declined approximately -9.15301% over the past 52 weeks. The 50-day moving average sits at 6.90, while the 200-day moving average is 7.40.
| Beta (5Y) | N/A |
| 52-Week Price Change | -9.15301% |
| 50-Day Moving Average | 6.90 |
| 200-Day Moving Average | 7.40 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Jinghua Pharmaceutical Group Co., Ltd. generated 1.41B in revenue and converted that into 207.86M in net income, yielding earnings per share of 0.30. EBITDA reached 267.98M, while operating income came in at 267.98M.
| Revenue | 1.41B |
| Gross Profit | 722.36M |
| Operating Income | 267.98M |
| Pretax Income | 285.92M |
| Net Income | 207.86M |
| EBITDA | 267.98M |
| EBIT | 267.98M |
| Earnings Per Share (EPS) | 0.30 |
Balance Sheet
Jinghua Pharmaceutical Group Co., Ltd. holds 1.09B in cash and equivalents against 212,558.73 in total debt, resulting in a net debt position of -794.71M. Total book value stands at 1.76B, with working capital of 1.50B providing operational flexibility.
| Cash & Cash Equivalents | 1.09B |
| Total Debt | 212,558.73 |
| Net Debt | -794.71M |
| Equity (Book Value) | 1.76B |
| Book Value Per Share | 2.16 |
| Working Capital | 1.50B |
Cash Flow
After subtracting -17.07M in capital expenditures, free cash flow totaled -17.07M - equivalent to -0.02 per share.
| Operating Cash Flow | N/A |
| Capital Expenditures | -17.07M |
| Free Cash Flow | -17.07M |
| FCF Per Share | -0.02 |
Margins
Jinghua Pharmaceutical Group Co., Ltd. operates with a gross margin of 51.12, reflecting its pricing power and cost economics. The operating margin of 18.96 and net profit margin of 14.71 provide insight into operational efficiency.
| Gross Margin | 51.12 |
| Operating Margin | 18.96 |
| Pretax Margin | 20.23 |
| Profit Margin | 14.71 |
| EBITDA Margin | 18.96 |
Dividends & Yields
The company's payout ratio of 23.60 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 0.08 |
| Dividend Yield | N/A |
| Payout Ratio | 23.60 |
| Shareholder Yield | 0.98 |
| FCF Yield | 0.29 |
Stock Splits
Jinghua Pharmaceutical Group Co., Ltd.'s most recent stock split took place on March 14, 2017 with a 1:2 split ratio.
| Last Split Date | 3/14/2017 |
| Split Ratio | 1:2 |
Scores
Jinghua Pharmaceutical Group Co., Ltd. posts an Altman Z-Score of 10.61, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 10.61 |